Competitive projects

Competitive projects ISABIAL

ReferenciaTítuloIPEntidad financiadora
PTA2024-025267-IR&D&I TECHNICAL STAFF GRANTS: Anabel Garcia HerediaAnabel García Heredia MINISTRY OF SCIENCE, INNOVATION AND UNIVERSITIES
PI25/02023Development of a personalised recommendation system to improve statin adherence based on Artificial Intelligence (GENADHEREC)Adriana López Pineda and Vicente Francisco Gil GuillénCarlos III Health Institute
PI25/01894Clinical and economic impact of personalised dosing through Clinical Pharmacokinetics of long‑acting antipsychotic treatment in patients with psychotic or psychoaffective disordersRicardo Nalda Molina y Amelia Ramón LópezCarlos III Health Institute
PI25/01956Analysis of the nasopharyngeal microbiome and virological, immune, and inflammatory factors associated with poor outcomes in adults hospitalised with influenza virus and respiratory syncytial virus (MiViFlu‑RSV)José Manuel Ramos Rincón and María Paz Ventero MartínCarlos III Health Institute
ICI25/00076Moderate versus restrictive fluid therapy in acute pancreatitis: a multicentre, randomised, controlled, open label trial WATERFINDEREnrique de Madaria PascualCarlos III Health Institute
PI25/02165Dysfunction of the apoE Pathway and Amyloid Metabolism: Implications for Alzheimer’s Pathogenesis and New Translational Approaches (TraslAPPOE)Javier Sáez Valero and Inmaculada Cuchillo IbáñezCarlos III Health Institute
PI25/01555HEROICA: Clinical Trial to Validate an AI‑Based Predictive Technological Model for Prescription Opioid Use Disorder, Based on Virtual Reality and Functional Magnetic Resonance ImagingAna María Peiró PeiróCarlos III Health Institute
PI25/00518Evaluation of Surveillance Intervals After Fragmented Resection of Non‑Pedunculated Colorectal Lesions ≥20 mm: SCARFACE Clinical TrialCarolina Mangas SanjuánCarlos III Health Institute
EXP_77443Biomechanical Evaluation of Balance, Gait, and Muscle Weakness Using Smartphone‑Integrated Inertial Sensors and Portable Dynamometry to Characterize Physical Deterioration in People with Multiple Sclerosis Across Different Disease Stages: A Cross‑Sectional StudyFrancisco David Barbado MurilloSpanish National Sports Council – Ministry of Culture and Sport “Funded by the European Union – Next Generation EU” “Spain Can”
INREIA/2024/131Artificial Intelligence Platform for the Early Detection of Alzheimer’s Disease through Voice (IAEAV)Ángel Constantino Pérez SempereRegional Ministry of Innovation, Industry, Trade and Tourism
CIAICO/2024/313Advancing the Search for Biomarkers of Alzheimer’s Disease (Avanz‑EA)Javier Sáez Valero and Inmaculada Cuchillo IbáñezRegional Ministry of Education, Culture, Universities and Employment
1011100633European Federation for Cancer Images (EUCAIM)Cristina Alenda GonzálezEuropean Commission
PI24/01970Early detection of disability progression in patients with multiple sclerosis without evidence of disease activityÁngel Constantino Pérez SempereCarlos III Health Institute
RD24/0014/0022Spanish Network for Advanced Therapies Plus (TERAV+)Salvador Martínez PérezCarlos III Health Institute
RD24/0003/0002Addiction Primary Care Research Network (RIAPAd)Jorge Manzanares RoblesCarlos III Health Institute
S2/4.5/F0254Geriatric Neurosurgery: Advancing Neurosurgical Care for Older People in South‑West Europe (GENEUS)Pablo González LopezInterreg-SUDOE
101183247Joint Action addressing DEmentia and Health (JADE Health)Carmen Díaz Marín and Francisco David Barbado MurilloEuropean Commission
AC24/00142Ecological monitoring for the assessment of frailty in older people (EMA_Frailty)Mª Luisa Ruiz MirallesCarlos III Health Institute
PI24/01343Effect of Different Cardiac Rehabilitation Methods on Endothelial Function in Patients with Ischaemic Heart Disease and Study of Associated Biophysiological Mechanisms (ENDO‑R)DO-R)Jose Manuel Sarabia MarinCarlos III Health Institute
PI24/01103Design and Evaluation of an Intervention to Support Decision‑Making on Place of Death in Palliative CareMaría Josefa Cabañero MartínezCarlos III Health Institute
PI24/01670Synergistic Effect of Systemic Translocation of Bacterial Genomic Antigens in Cirrhotic Patients with Hepatocellular Carcinoma Treated with ImmunotherapyPedro Zapater HernándezCarlos III Health Institute
DTS24/00015Technological Validation and Clinical Efficacy of HEFMOB: A Virtual Reality Device for Early Mobilisation and Monitoring in Patients with Heart FailureVicente Climent PayáCarlos III Health Institute
CIPROM/2023/4The MASLD-inflammasome axis in inflammatory disease and tumor developmentJose Manuel González Navajas and Rodrigo Joaquín Jover MartínezRegional Ministry of Education, Culture, Universities and Employment, through the 2024 R&D&I Programme – PROMETEO Grants for Excellence Research Groups
CIPROM/2023/12Identification and validation of new techniques for the diagnosis of pancreatic insufficiency, the WATERLADY projectEnrique de Madaria PascualRegional Ministry of Education, Culture, Universities and Employment, through the 2024 R&D&I Programme – PROMETEO Grants for Excellence Research Groups
INNEST/2024/514Study for the Development of New Easy‑to‑Swallow Formats Using Alternative Compounding and 3D Printing TechnologiesPedro García SalomValencian Institute for Competitiveness and Innovation (IVACE+i)
INNVA1/2024/45Customisable Vascular Simulator Tailored to Each Patient’s Anatomy for High‑Precision Surgical Planning and Specialised Medical TrainingFrancisco Javier Esclapés JoverValencian Institute for Competitiveness and Innovation (IVACE+i)
INNVA1/2024/44Middle Meningeal Artery Simulator for Embolic SubstancesFrancisco Javier Esclapés JoverValencian Institute for Competitiveness and Innovation (IVACE+i)
INNTA1/2024/39SmartHealth: Synergies in Clinical Research and Technologies from the ISABIAL InstituteÓscar Moreno PérezValencian Institute for Competitiveness and Innovation (IVACE+i)
CNS2023-145676Effect of Salt Intake on the Efficacy of Immune Checkpoint Therapy (ICYSALT)José Manuel González NavajasMinistry of Science and Innovation – Spanish State Research Agency
IFEQ22/00119Acquisition of Equipment and Infrastructure at ISABIAL: CAE VIMEDIX Virtual Reality Simulator for Training in Transesophageal and Abdominal / eFAST EchocardiographyJuan Carlos Rodríguez DíazCarlos III Health Institute
IFEQ22/00118Acquisition of Equipment and Infrastructure at ISABIAL: Leica Thunder 3D Assay MicroscopeJuan Carlos Rodríguez DíazCarlos III Health Institute
IFEQ22/00116 Acquisition of ISABIAL Equipment and Infrastructure: GridION Mk1 CapEx + Software LicenceJuan Carlos Rodríguez DíazCarlos III Health Institute
RD21/0017/0017Advanced Therapies Network: RICORS TERAVSalvador Martínez PérezCarlos III Health Institute
RD21/0016/0024Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS)Vicente Gil CuillénCarlos III Health Institute
RD21/0009/0008Research Network on Primary Care and Addictions (RIAPad)Jorge Manzanares RoblesCarlos III Health Institute
PT23/00126Clinical Research Support Unit for Non‑Pharmacological Interventions INCLINAS (Clinical Research in Non‑Pharmacological Interventions)Mª Isabel Orts CortésCarlos III Health Institute
PMP21/00082Therapeutic targets and biomarkers from precision medicine in MAFLD (PreMed-MAFLD)Rubén Francés GuarinosCarlos III Health Institute
PID2022-143269OB-I00Role of T Cells in the Regeneration of Aged or Chronically Injured Peripheral NervesJosé Antonio Gómez SánchezMinistry of Science and Innovation
PID2022-137426OA-I00Characterization of Brain Extracellular Vesicle Subpopulations: Toward the Identification of Novel Biomarkers and Therapeutic Targets in Alzheimer’s Disease (EV2TRACK_AD)Rocío Pérez GonzálezMinistry of Science and Innovation
PID2021-124465OA-I00Conditioning and Memory of Oligodendrocyte Progenitor Cells (OPCs): Do OPCs Remember Inflammatory Processes?Alerie Guzmán de la FuenteMinistry of Science and Innovation
PI23/01974Surveillance After Colonic Lesion Removal: Comparison of Intervals and Factors Related to the Persistence of Colorectal Cancer RiskRodrigo Jover MartínezCarlos III Health Institute
PI23/01858Multioomic Classification of Patients and New Pharmacological Screening Models in Huntington’s DiseaseLuis Miguel Valor BecerraCarlos III Health Institute
PI23/01568Factors Associated with the Transmission of the Mediterranean Diet from Mothers to Children During Childhood and Its Association with Urinary Environmental Contaminants and Cardiometabolic Risk MarkersSandra González PalaciosCarlos III Health Institute
PI22/01907Multicytokine‑Blocking Strategy to Reduce the Development of Hepatocellular Carcinoma and Improve Immune Checkpoint Inhibition TherapyJosé Manuel González NavajasCarlos III Health Institute
PI22/01329Sentinel Biomarkers of apoE and APP Pathway Alterations in Alzheimer’s Disease and Their Validation in Cellular Models (CHIVAT‑AD)Javier Sáez ValeroCarlos III Health Institute
PI22/01312New Grass Pollen Allergens Induced by Urban Pollution: Identification and Clinical Evaluation in Patients with Seasonal Allergic RhinitisVíctor Soriano GomisCarlos III Health Institute
PI22/00980Lactated Ringer’s Solution–Based Fluid Therapy Versus Normal Saline in Acute Pancreatitis: International Multicenter Randomized Clinical Trial (GALADRIE Study)Enrique de Madaria PascualCarlos III Health Institute
PI21/01702Chemokine and Receptor Expression Profile in Response to Immunomodulatory Treatment in Tissue from Patients with Crohn’s Disease (TraffEC Study)Ana Gutiérrez CasbasCarlos III Health Institute
PI21/01012Unraveling the Silencing Mechanisms and Behavior of Silent Corticotroph Tumors: Clinical ImplicationsAntonio Miguel Picó AlfonsoCarlos III Health Institute
PI21/00738Impact of Hospitalization on Nutritional Status and Dysphagia Risk in Adults Aged 65 Years and Older. Multicenter “NUTRIFAG” StudyMª Isabel Orts CortésCarlos III Health Institute
PI21/00544Synovial and Systemic Inflammation Associated with Silent Urate Crystal Deposition in Asymptomatic HyperuricemiaMariano Andrés ColladoCarlos III Health Institute
PI21/00488Identification of cannabinoid biomarkers in alcohol dependence: translational research and new therapeutic strategies. Cannabial project. Animal studiesJorge Manzanares RoblesCarlos III Health Institute
PI20/01527Risk of colorectal cancer after resection of advanced polypsRodrigo Jover MartínezCarlos III Health Institute
ICI23/00099Phase III Randomized, Double‑Blind, Multicenter Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared with Placebo in Patients with Severe Influenza (FLUDEX Trial)Esperanza Merino de LucasCarlos III Health Institute
ICI21/00016Combined Cell Therapy for High‑Mortality‑Risk COVID‑19 Patients (DECODE‑19)Bernat Soria EscomsCarlos III Health Institute
ICI20/00146Gender Bias in Pain Medicine: From Omics to Healthcare (SESGEN)Ana María Peiró Peiró Carlos III Health Institute
ICI20/00060Ursodeoxycholic Acid vs Placebo for the Prevention of Recurrent Acute Biliary Pancreatitis: A Multicenter, Randomized, Double‑Blind, Placebo‑Controlled Clinical TrialEnrique de Madaria Pascual Carlos III Health Institute
DTS21/00171Development of an Early Mobilization Prototype for Heart Failure and Its Implementation in a Real‑World Setting: Heart Failure Mobilization (HeFMob II)Vicente Climent PayáCarlos III Health Institute
CPP2022-010089Cost-effective, safe and hla-compliant cell therapy for critical threatening limb ischaemiaBernat Soria EscomsMinistry of Science and Innovation
CPP2021-008379Clinical trial to evaluate the administration of ApTOLL in Acute Myocardial Infarction - ApSTEMIJuan Miguel Ruiz NodarMinistry of Science and Innovation
CPII20/00025Miguel Servet Type II ContractsLuis Miguel Valor BecerraCarlos III Health Institute
CP22/00078Rejuvenating Schwann cells to restore the regeneration failure of aged and chronically injured nerves.José Antonio Gómez SánchezCarlos III Health Institute
CP21/00032The Role of Adult Brain Stem Cells in Neurodegenerative DiseasesAlerie Guzmán de la FuenteCarlos III Health Institute
CP21/00009The Role of Extracellular Vesicles in Neurodegenerative Diseases and Their Potential to Serve as Reporters of Brain PathologyRocío Pérez GonzálezCarlos III Health Institute
CNS2022-136169Neuroinflammation in Huntington’s Disease: Mouse Modelling and Peripheral Correlates in Patients (NInf‑Hunt)Luis Miguel Valor BecerraMinistry of Science and Innovation
CIPROM/2021/048Conundrum on research in corneal nerve regeneration (CORNER2) / Interrogantes en investigación sobre la regeneración de los nervios cornealesJuana Gallar MartínezRegional Ministry of Innovation, Universities, Science and Digital Society
CDEI-03/20-APlan GenT Act 1 - The salt–Th17 axis in tumor growth and response to immunotherapy in hepatocellular carcinoma (Contrato)José Manuel González NavajasGovernment of the Valencian Community – Regional Ministry of Health
AC22/00050Defining (sex‑ and age‑dependent) the cell‑type‑specific epigenetic mechanisms underlying enriched environment/exercise as non‑pharmacological interventions for Huntington’s and Alzheimer’s diseases, and their potential as biomarkersRocío Pérez GonzálezCarlos III Health Institute
2023I031Project MORPHEO: National Collaborative Study to Evaluate the Effectiveness and Efficiency of Implementing a Predictive Model for Prescription Opioid Use Disorder Risk Using Artificial Intelligence TechniquesAna María Peiró PeiróMinistry of Health and Social Policy
101126953Joint Action on Cardiovascular Diseases and Diabetes (JACARDI)Óscar Moreno PérezEuropean Commission
101061179Mediterranean Researchers' Night Goes To School (MEDNIGHT GTS)Ana Martínez CantoEuropean Commission
IFEQ21/00201Cell Processing Platform for the Advanced Therapies Unit of ISABIALÓscar Moreno Pérez Carlos III Health Institute
IFEQ21/00184Containerised System with Storage Array, Management System and Computing Infrastructure for the Data Management, Medical Imaging and Artificial Intelligence (AI) Unit of ISABIALÓscar Moreno PérezCarlos III Health Institute
INNTA1/2023/29Maintenance of the Innovation Agent: Towards the Integration of ISABIAL’s Innovation Activity with Its SurroundingsCarla Ordiñana GilValencian Innovation Agency (AVI)
INNEST/2023/1Artificial Intelligence Platform for the Design and Development of New Healthy Products in the Agri‑Food SectorÓscar MorenoValencian Innovation Agency (AVI)
INNCP2/2022/3Development of the Innovation Public Procurement Model at the Alicante Institute for Health and Biomedical Research (ISABIAL)Carla Ordiñana GilValencian Innovation Agency (AVI)
INNTA1/2022/33Synergies in Clinical Research and Enabling Technologies Fostered by the ISABIAL InstituteAlexandra Gomis PontValencian Innovation Agency (AVI)
INNEST/2022/54Advanced Text Analysis Platform for Extracting Trends and Knowledge from Scientific‑Technical Documents Using NLP Techniques (T2KNOW)Alexandra Gomis PontValencian Innovation Agency (AVI)
INNEST/2022/96Precision Surgical Planning Guided by Identity‑Based Habitats of Glial Tumours to Enable Intraoperative Immunotherapy Decision‑MakingCristina Alenda GonzálezValencian Innovation Agency (AVI)
INNEST/2022/168Comprehensive and Intelligent Platform for Precision Medicine Applied to Brain TumoursLuis Miguel Valor BecerraValencian Innovation Agency (AVI)
INNEST/2021/59Intelligent Decision‑Support System for Precision Medicine in Clinical Practice – OGMIOSVicente Climent y Amaya GarcíaValencian Innovation Agency (AVI)
INNTA1/2021/23Boosting Innovation Developed at ISABIAL and Its Transfer Through the Innovation AgentCarla OrdiñanaValencian Innovation Agency (AVI)
INNVA1/2020/5Design of a Prototype to Promote Early In‑Hospital Mobilisation in Patients After an Episode of Decompensated Heart Failure (Phase II): Development and Pilot Testing of HeFMobVicente Eduardo ClimentValencian Innovation Agency (AVI)
2019-1-ES01-KA203-065060Housing as a Strategy for the Promotion of Health from an Intersectoral and Multidisciplinary ApproachEUROPEAN COMMISSION-DG EDUCATION AND CULTURE
PI18/01547Sex–Gender Interaction in Inflammatory Bowel Disease: What Are the Connections and Why Do They MatterLaura SempereCarlos III Health Institute
RD16/0025/0037Spanish HIV Research NetworkJoaquín PortillaCarlos III Health Institute
PI15/01344Effectiveness of Installing Antimicrobial Filters in Water Taps in Critical Care Units to Prevent the Occurrence of Healthcare‑Associated Infections Caused by Pseudomonas aeruginosaJosé SánchezCarlos III Health Institute
PI14/01386Factors Related to the Quality of Colonoscopy in Clinical PracticeRodrigo JoverCarlos III Health Institute
CPP2021-008379Clinical trial to evaluate the administration of ApTOLL in Acute Myocardial Infarction – ApSTEMIJuan Miguel Ruiz Ministry of Science and Innovation – Spanish State Research Agency

Contact

Carles Blasco 965 913 941
Miguel Tirado 965 913 985
Pablo Flores 965 913 999
Raquel Molina
proyectos@isabial.es

Location

Ground Floor Modular offices (Opposite the IT department)
Dr. Balmis General University Hospital
Avda. Pintor Baeza, 12, 03010 Alicante

Hours

Monday to Friday
9:00 AM to 2:30 PM

Back To Top
No results found...